Elizabeth Nabel, MD, the director of the National Heart, Lung, and Blood Institute (NHLBI), was named the next president of Brigham and Women’s/Faulkner Hospitals. A board... | [more]
Welcome to Dana-Farber/Harvard Cancer Center
Dana-Farber/Harvard Cancer Center (DF/HCC) is the largest comprehensive cancer center in the world, bringing together the cancer research efforts of our seven member institutions: Beth Israel Deaconess Medical Center, Brigham and Women’s Hospital, Children’s Hospital Boston, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health, and Massachusetts General Hospital.Funded by a grant from the National Cancer Institute, we have joined these seven renowned Harvard-affiliated medical centers into one collective force dedicated to the fight against cancer. Based in Boston, DF/HCC consists of more than 1,000 researchers with a singular goal — to find new and innovative ways to combat cancer.
Announcements
- Harvard Catalyst awards its second round of pilot grants Posted: 11-19-09
- Cancer Chemical Biology Seminar Series Posted: 11-18-09
- 24th Apffel Memorial Lecture Posted: 11-16-09
Latest Cancer News
BWH names Nabel next president
Szostak wins Nobel Prize
The Royal Swedish Academy of Sciences announced recently that the 2009 Nobel Prize in Physiology or Medicine was awarded to Jack Szostak, a Howard Hughes Medical Institute... | [more]
Fall eNews
The Fall edition of eNews, DF/HCC's quarterly newsletter, has just been published. This issue includes a feature article on myeloma research and a spotlight section... | [more]
Bench to bedside translational science doubling myeloma survival
“I’ve been at this for 30 years and the last five years have been truly remarkable,” says Kenneth Anderson, MD (DFCI). He is speaking of the stretch of successes in the field... | [more]
